Education
About Us
Working with TipRanks
Follow Us
Erika Carmel Ltd. (IL:BCUR)
:BCUR
BCUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range16.90 - 40.00
Previous CloseN/A
Volume27.94K
Average Volume (3M)87.00K
Market Cap
22.29M
Enterprise Value714.48M
Total Cash (Recent Filing)4.15M
Total Debt (Recent Filing)3.09M
Price to Earnings (P/E)―
Beta0.60
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding104,165,290
10 Day Avg. Volume128,711
30 Day Avg. Volume87,005
Financial Highlights & Ratios
PEG Ratio-38.86
Price to Book (P/B)227.24
Price to Sales (P/S)0.00
P/FCF Ratio143.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Erika B-Cure News
BCUR FAQ
What was Erika Carmel Ltd.’s price range in the past 12 months?
Erika Carmel Ltd. lowest stock price was 16.90 and its highest was 40.00 in the past 12 months.
What is Erika Carmel Ltd.’s market cap?
Erika Carmel Ltd.’s market cap is 22.29M.
When is Erika Carmel Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Erika Carmel Ltd.’s earnings last quarter?
Erika Carmel Ltd. released its earnings results on Aug 31, 2021. The company reported 1.3 earnings per share for the quarter, beating the consensus estimate of N/A by 1.3.
Is Erika Carmel Ltd. overvalued?
According to Wall Street analysts Erika Carmel Ltd.’s price is currently Overvalued.
Does Erika Carmel Ltd. pay dividends?
Erika Carmel Ltd. does not currently pay dividends.
What is Erika Carmel Ltd.’s EPS estimate?
Erika Carmel Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Erika Carmel Ltd. have?
Erika Carmel Ltd. has 104,165,290 shares outstanding.
What happened to Erika Carmel Ltd.’s price movement after its last earnings report?
Erika Carmel Ltd. reported an EPS of 1.3 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Erika Carmel Ltd.?
Currently, no hedge funds are holding shares in IL:BCUR
Company Description
Erika Carmel Ltd.
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic problems, diabetic wounds, and difficulties in healing and mucositis. The company also provides B-Cure Laser Sport, a home device for treating injuries and sports pain, orthopedics, and others; and B-Cure Laser Sport Pro, a professional device for treating sports injuries, and pain relief in areas of the body and muscles, as well as infections, including Achilles tendonitis. In addition, it offers B-Cure Laser Dental, a device for use in dental clinics to treat dental problems, relieve gum pain, and inflammation, as well as helps in the recovery process after dental treatment, including implants, and in reducing pain and swelling; and B-Pro Dental Laser Cure, a device for the treatment of dental problems and infections in dental clinics. The company was formerly known as Erica Carmel Ltd and changed its name to Erika B-Cure Laser Ltd in January 2022. Erika B-Cure Laser Ltd was incorporated in 2007 and is headquartered in Haifa, Israel.
Technical Analysis
Bio View
―
Allmed Solution
―
Elbit Medical Technologies Ltd
―
Human Xt
―
Mediprss Pu
―